A dome-shaped elastic poly(l-lactide-co-caprolactone) (PLCL) scaffold with a channel and pore structure was fabricated by a combinative method of 3D printing technology and the gel pressing method (13 mm in diameter and 6.5 mm in thickness) for patient-specific regeneration. The PLCL scaffold was combined with adipose decellularized extracellular matrix (adECM) and heart decellularized extracellular matrix (hdECM) hydrogels and human adipose-derived stem cells (hADSCs) to promote adipogenesis and angiogenesis. These scaffolds had mechanical properties similar to those of native adipose tissue for improved tissue regeneration. The results of the in vitro real-time PCR showed that the dECM hydrogel mixture induces adipogenesis. In addition, the in vivo study at 12 weeks demonstrated that the tissue-engineered PLCL scaffolds containing the hydrogel mixture (hdECM/adECM (80:20)) and hADSCs promoted angiogenesis and adipose tissue formation, and suppressed apoptosis. Therefore, we expect that our constructs will be clinically applicable as material for the regeneration of patient-specific large-sized adipose tissue.
High LOX levels in the tumor microenvironment causes the cross-linking of extracellular matrix components and increases the stiffness of tumor tissue. Thus, LOX plays an important role in tumorigenesis and in lowering the tumor response to anticancer drugs. Despite comprehensive efforts to identify the roles of LOX in the tumor microenvironment, sensitive and accurate detection methods have not yet been established. Here, we suggest the use of gold nanoparticles functionalized with LOX-sensitive peptides (LS-AuNPs) that aggregate upon exposure to LOX, resulting in a visual color change. LOX-sensitive peptides (LS-peptides) contain lysine residues that are converted to allysine in the presence of LOX, which is highly reactive and binds to adjacent allysine, resulting in the aggregation of the AuNPs. We demonstrated that the synthesized LS-AuNPs are capable of detecting LOX sensitively, specifically both in vitro and in the tissue extract. Moreover, the suggested LS-AuNP-based assay is more sensitive than commonly employed assays or commercially available kits. Therefore, the LS-AuNPs developed in this study can be used to detect LOX levels and can be further used to predict the stiffness or the anticancer drug resistance of the tumor.
To address the demand for reconstructive procedures in extensive subcutaneous tissue defects and significant dermis matrix loss, vascularized adipose tissue regeneration is essential for maintaining volume after material degradation. Accordingly, a double‐crosslinked hydrogel that combines polyethylene glycol (PEG)‐crosslinked carboxymethyl chitosan (CMC) with a hybrid decellularized extracellular matrix (dECM) is developed. The dECM, sourced from porcine adipose and cardiac tissues, processed using a supercritical fluid technique (scCO2‐EtOH) retains 1.5–5‐fold more angiogenic and adipogenic cytokines than that processed using traditional methods. This hybrid dECM‐based filler demonstrates excellent physical properties and injectability, with injection forces being significantly less than that for crosslinked hyaluronic acid (HA) fillers. Upon incubation at 37 °C, the storage modulus of the fillers increases substantially, eventually enhancing their moldability from additional crosslinking and the thermosensitive nature of collagen. Assessments in a UVB‐induced photoaging mouse model indicate that the material maintains superior shape stability, durability, and supports vascularized tissue regeneration, reduces inflammation, and enhances VEGF expression and ECM maturation more effectively compared with that using other fillers. These promising results suggest that the material can serve as a highly effective multifunctional solution for injectable regenerative medical applications and is well‐suited for potential clinical trials.
Hair loss associated with inflammatory scalp conditions is a growing clinical challenge. However, current FDA‐approved treatments primarily stimulate hair growth without targeting the underlying oxidative stress or immune‐related damage. In this study, we developed a topical, bioactive composite composed of amine‐activated carboxymethyl chitosan (aaCMC) and hydrolyzed decellularized extracellular matrix (h‐dECM), formulated using a dual supercritical fluid system to ensure solubility and enhance skin penetration. The resulting formulation exhibited antioxidant activity, immunomodulatory effects, and promoted extracellular matrix (ECM) remodeling in vitro. Specifically, the aaCMC + h‐dECM composite reduced intracellular reactive oxygen species (ROS) levels and suppressed p38 phosphorylation in human dermal papilla cells, indicating the inhibition of senescence‐related pathways. It also attenuated pro‐inflammatory cytokine secretion in activated human peripheral blood mononuclear cells and significantly upregulated collagen and fibronectin expression in human dermal fibroblasts. In vivo, the composite accelerated epidermal repair and hair follicle regeneration in a UVB‐induced scalp injury mouse model, demonstrating superior regenerative outcomes compared with minoxidil. These results suggest that aaCMC + h‐dECM is a multi‐functional regenerative platform capable of restoring scalp homeostasis through the combination of ROS modulation, immune regulation, and ECM support. This strategy may provide a multi‐functional therapeutic alternative to conventional monotherapies for inflammatory hair loss.